Craig L. Duvall School of Engineering Vanderbilt University Biography Publications Institution JoVE Articles Craig L. Duvall has not added a biography. If you are Craig L. Duvall and would like to personalize this page please email our Author Liaison for assistance. Publications Subfailure Overstretch Injury Leads to Reversible Functional Impairment and Purinergic P2X7 Receptor Activation in Intact Vascular Tissue Frontiers in Bioengineering and Biotechnology. 2016 | Pubmed ID: 27747211 Local Delivery of PHD2 SiRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound Healing Advanced Healthcare Materials. Sep, 2016 | Pubmed ID: 27717176 Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids As Anti-MicroRNA Therapies Advanced Materials (Deerfield Beach, Fla.). Sep, 2016 | Pubmed ID: 27383910 Hydrophobic Interactions Between Polymeric Carrier and Palmitic Acid-conjugated SiRNA Improve PEGylated Polyplex Stability and Enhance In vivo Pharmacokinetics and Tumor Gene Silencing Biomaterials. Aug, 2016 | Pubmed ID: 27163624 Fluorocoxib A Loaded Nanoparticles Enable Targeted Visualization of Cyclooxygenase-2 in Inflammation and Cancer Biomaterials. Jun, 2016 | Pubmed ID: 27043768 Hydrolytic Charge-reversal of PEGylated Polyplexes Enhances Intracellular Un-packaging and Activity of SiRNA Journal of Biomedical Materials Research. Part A. Apr, 2016 | Pubmed ID: 26691570 High Conversion of HAuCl4 into Gold Nanorods: A Re-seeding Approach Journal of Colloid and Interface Science. Feb, 2016 | Pubmed ID: 26550780 Particle-based Technologies for Osteoarthritis Detection and Therapy Drug Delivery and Translational Research. Apr, 2016 | Pubmed ID: 25990835 Technologies for Controlled, Local Delivery of SiRNA Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2015 | Pubmed ID: 26476177 Fibrinolysis is Essential for Fracture Repair and Prevention of Heterotopic Ossification The Journal of Clinical Investigation. Sep, 2015 | Pubmed ID: 26325037 Fibrinolysis is Essential for Fracture Repair and Prevention of Heterotopic Ossification The Journal of Clinical Investigation. Aug, 2015 | Pubmed ID: 26214526 Shape-engineered Multifunctional Porous Silicon Nanoparticles by Direct Imprinting Nanotechnology. Jul, 2015 | Pubmed ID: 26081802 MK2 Inhibitory Peptide Delivered in Nanopolyplexes Prevents Vascular Graft Intimal Hyperplasia Science Translational Medicine. Jun, 2015 | Pubmed ID: 26062847 Endosomolytic Nano-Polyplex Platform Technology for Cytosolic Peptide Delivery To Inhibit Pathological Vasoconstriction ACS Nano. Jun, 2015 | Pubmed ID: 26004140 A Transient Cell-shielding Method for Viable MSC Delivery Within Hydrophobic Scaffolds Polymerized in Situ Biomaterials. Jun, 2015 | Pubmed ID: 25907036 Conjugation of Palmitic Acid Improves Potency and Longevity of SiRNA Delivered Via Endosomolytic Polymer Nanoparticles Journal of Biomedical Materials Research. Part A. Sep, 2015 | Pubmed ID: 25641816 MiRNA Inhibition in Tissue Engineering and Regenerative Medicine Advanced Drug Delivery Reviews. Jul, 2015 | Pubmed ID: 25553957 ROS-responsive Microspheres for on Demand Antioxidant Therapy in a Model of Diabetic Peripheral Arterial Disease Biomaterials. Feb, 2015 | Pubmed ID: 25522975 Tuning PEGylation of Mixed Micelles to Overcome Intracellular and Systemic SiRNA Delivery Barriers Biomaterials. Jan, 2015 | Pubmed ID: 25453977 Dual MMP7-proximity-activated and Folate Receptor-targeted Nanoparticles for SiRNA Delivery Biomacromolecules. Jan, 2015 | Pubmed ID: 25414930 Quantifying the Vascular Response to Ischemia with Speckle Variance Optical Coherence Tomography Biomedical Optics Express. Dec, 2014 | Pubmed ID: 25574425 Enhanced Performance of Plasmid DNA Polyplexes Stabilized by a Combination of Core Hydrophobicity and Surface PEGylation Journal of Materials Chemistry. B, Materials for Biology and Medicine. Dec, 2014 | Pubmed ID: 25530856 Future Nanomedicine for the Diagnosis and Treatment of Osteoarthritis Nanomedicine (London, England). Jul, 2014 | Pubmed ID: 25405797 Cell Protective, ABC Triblock Polymer-based Thermoresponsive Hydrogels with ROS-triggered Degradation and Drug Release Journal of the American Chemical Society. Oct, 2014 | Pubmed ID: 25254509 In Situ Synthesis of Peptide Nucleic Acids in Porous Silicon for Drug Delivery and Biosensing Bioconjugate Chemistry. Jul, 2014 | Pubmed ID: 24949894 In Vivo Imaging of Nanoparticle Delivery and Tumor Microvasculature with Multimodal Optical Coherence Tomography Biomedical Optics Express. Jun, 2014 | Pubmed ID: 24940536 A Porous Tissue Engineering Scaffold Selectively Degraded by Cell-generated Reactive Oxygen Species Biomaterials. Apr, 2014 | Pubmed ID: 24491510 Tunable Delivery of SiRNA from a Biodegradable Scaffold to Promote Angiogenesis in Vivo Advanced Materials (Deerfield Beach, Fla.). Jan, 2014 | Pubmed ID: 24338842 Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for SiRNA Delivery Advanced Functional Materials. Jun, 2013 | Pubmed ID: 25214828 SiRNA Delivery from an Injectable Scaffold for Wound Therapy Advances in Wound Care. Apr, 2013 | Pubmed ID: 24527332 Balancing Cationic and Hydrophobic Content of PEGylated SiRNA Polyplexes Enhances Endosome Escape, Stability, Blood Circulation Time, and Bioactivity in Vivo ACS Nano. Oct, 2013 | Pubmed ID: 24041122 Quantitative Optical Imaging of Vascular Response in Vivo in a Model of Peripheral Arterial Disease American Journal of Physiology. Heart and Circulatory Physiology. Oct, 2013 | Pubmed ID: 23955718 Nanocarriers for Dual Delivery of Doxorubicin and SiRNA to Overcome Multidrug Resistance Nanomedicine (London, England). Mar, 2013 | Pubmed ID: 23477333 デュアル PH と温度応答微粒子タンパク質デリバリー虚血組織へ。 Acta Biomaterialia. Feb, 2013 | Pubmed ID: 23402764 高分子ミセルの「クリック」、Mannosylated 経由でのターゲット マクロファージの RNA 干渉。 Molecular Pharmaceutics. Mar, 2013 | Pubmed ID: 23331322 Ex Vivo 代謝計測培養組織から生体内組織の状態を反映してください。 Journal of Biomedical Optics. Nov, 2012 | Pubmed ID: 23117810 細胞内の配信は、リンパ腫を対象とした抗体高分子共役の人身売買のダイナミクス。 Molecular Pharmaceutics. Nov, 2012 | Pubmed ID: 23075320 Poly(PS-b-DMA) ミセル活性酸素種の薬物放出をトリガーしました。 Journal of Controlled Release : Official Journal of the Controlled Release Society. Sep, 2012 | Pubmed ID: 22889714 注射用足場から SiRNA の持続的な配達。 Biomaterials. Feb, 2012 | Pubmed ID: 22061489 PH 依存性の膜の不安定化、蛋白質の循環時間を向上させるいかだ合成グラフト共重合体。 Journal of Controlled Release : Official Journal of the Controlled Release Society. Oct, 2011 | Pubmed ID: 21699931 アポトーシス誘導療法の細胞内作用する生物学的製剤の配信。 Current Pharmaceutical Design. 2011 | Pubmed ID: 21348831 タンパク質抗原エンドソームを解放するポリマーの細胞内動態 CD8 T 細胞の生産と予防ワクチンの有効性を高めます。 Bioconjugate Chemistry. Dec, 2010 | Pubmed ID: 21043513 持続的な VEGF 配信 PLGA ナノ粒子による血管の成長を促進します。 American Journal of Physiology. Heart and Circulatory Physiology. Jun, 2010 | Pubmed ID: 20228260 アポトーシス ペプチドいかだへの細胞内動態 Endosomolytic 高分子を合成しました。 Molecular Pharmaceutics. Apr, 2010 | Pubmed ID: 19968323 プロリル水酸化酵素阻害剤は促進を増やすし、マウスの大腿骨骨折後形成します。 Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. Oct, 2009 | Pubmed ID: 19338032 新規 Endosomolytic のジブロック共重合体を用いた SiRNA 送達の開発。 Journal of Controlled Release : Official Journal of the Controlled Release Society. Feb, 2009 | Pubmed ID: 18973780 組織統合と多孔質生体の 3 D イメージング。 Biomaterials. Oct, 2008 | Pubmed ID: 18635260 下肢虚血からの回復における Osteopontin の役割。 Arteriosclerosis, Thrombosis, and Vascular Biology. Feb, 2008 | Pubmed ID: 18006856 ホスト免疫能力と局所虚血人工血管の機能に影響を与えます。 Microcirculation (New York, N.Y. : 1994). Feb, 2007 | Pubmed ID: 17365663 オステオポンチン欠損マウスの癒しの破壊障害血管新生、初期のカルス形成と後期に改造します。 Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research. Feb, 2007 | Pubmed ID: 17087627 虚血性損傷後の血管の開発の定量的マイクロ トモグラフィの解析。 American Journal of Physiology. Heart and Circulatory Physiology. Jul, 2004 | Pubmed ID: 15016633 無傷のマウスの膵島のβ細胞のマイトジェンの持続的投与 Raymond C. Pasek1, Taylor E. Kavanaugh2, Craig L. Duvall2, Maureen A. Gannon1,3 1Department of Medicine, Vanderbilt University Medical Center, 2School of Engineering, Vanderbilt University, 3Department of Veterans Affairs, Tennessee Valley Health Authority Bioengineering 生体高分子薬の細胞質ゾルデリバリーのためのpH応答性エンドソーム溶解剤の評価のためにex vivoで赤血球溶血アッセイ Brian C. Evans*1,2, Christopher E. Nelson*1,2, Shann S. Yu*1,2, Kelsey R. Beavers2,3, Arnold J. Kim1, Hongmei Li1,2, Heather M. Nelson4, Todd D. Giorgio1,2,5,6, Craig L. Duvall1,2 1Department of Biomedical Engineering, Vanderbilt University, 2Vanderbilt Institute for Nanoscale Science & Engineering, Vanderbilt University, 3Interdisciplinary Materials Science Program, Vanderbilt University, 4Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, 5Department of Chemical & Biomolecular Engineering, Vanderbilt University, 6Department of Cancer Biology, Vanderbilt University JoVE 50166 Immunology and Infection
無傷のマウスの膵島のβ細胞のマイトジェンの持続的投与 Raymond C. Pasek1, Taylor E. Kavanaugh2, Craig L. Duvall2, Maureen A. Gannon1,3 1Department of Medicine, Vanderbilt University Medical Center, 2School of Engineering, Vanderbilt University, 3Department of Veterans Affairs, Tennessee Valley Health Authority Bioengineering
生体高分子薬の細胞質ゾルデリバリーのためのpH応答性エンドソーム溶解剤の評価のためにex vivoで赤血球溶血アッセイ Brian C. Evans*1,2, Christopher E. Nelson*1,2, Shann S. Yu*1,2, Kelsey R. Beavers2,3, Arnold J. Kim1, Hongmei Li1,2, Heather M. Nelson4, Todd D. Giorgio1,2,5,6, Craig L. Duvall1,2 1Department of Biomedical Engineering, Vanderbilt University, 2Vanderbilt Institute for Nanoscale Science & Engineering, Vanderbilt University, 3Interdisciplinary Materials Science Program, Vanderbilt University, 4Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, 5Department of Chemical & Biomolecular Engineering, Vanderbilt University, 6Department of Cancer Biology, Vanderbilt University JoVE 50166 Immunology and Infection
